Home » Glenmark Achieves Positive Results for Anti-Diarrhea Molecule
Glenmark Achieves Positive Results for Anti-Diarrhea Molecule
Drug firm Glenmark Pharmaceuticals Monday said it has achieved positive results in human trials for its new drug molecule Crofelemer, which is aimed at treating diarrhea in adults.
Economic Times
Economic Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May